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The role of hypochlorite ion, which can be generated by the enzyme myleoperoxidase, in
the biochemistry of gold(I) anti-arthritic drugs was investigated. Sodium hypochlorite (OCI-)
directly and rapidly oxidizes AuSTm, Au(CN)2-, AuSTg (gold thioglucose) and auranofin
(Et3PAuSATg). The resulting gold(Ill) species were detected by an Ion Chromotography Ion-Pairing
technique that was developed to distinguish gold(I) and gold(Ill). Formation of Au(lll) was also
demonstrated spectrophotometrically after the conversion to AuCI4-. The reactions of AuSTm,
AuSTg, and auranofin are complex and gold(Ill) appears only after the initial oxidation of the thiolate
(and phosphine)ligands.
The enzymatic reaction, using MPO with H202 and CI- as substrates, leads to slow
oxidation of Au(CN)2-, AuSTm or AuSTg. The extent and rate of reaction depend on the
concentrations of MPO, H202, and Au(I). The continued presence of Au(I) during the initial stages
of reaction (oxidation of the thiolates in AuSTm and AuSTg) and the conversion to Au(lll) in the
latter stages of the reaction were demonstrated.
Au(CN)2 a gold metabolite, binds tightly to serum albumin. Unlike other gold(I)
complexes, aurocyanide reacts almost negligibly at Cys-34 via ligand exchange. Instead, there is
a strong association (K 5.5 x 104 and K2 7.0 x 10; n 0.8 and n2 3) of intact Au(CN)2-.
The full extent of binding is revealed only by equilibrium methods such as NMR or ultrafiltration; the
bound gold dissociates extensively on conventional gel-exclusion columns and partially on
Penefesky spun columns.
The immunological and pharmacological significance of these results are discussed.
INTRODUCTION
The mechanism of action of anti-arthritic gold drugs has been a matter of speculation and
research for almost six decades. Strong evidence suggests that the bulk of gold in vivo, especially
the circulating metabolites, remain gold(I), the oxidation state present in myochrysin, solganol, and
auranofin [1]. Thus, it is interesting that immunological results in animal models [2] and humans
[3] suggest a role for gold(Ill). This prompted us to reexamine the cursory report [4] that gold(I)
can be oxidized by hypochlorite ion generated from H202 and CI- in the presence of the enzyme
myleoperoxidase (MPO) which is produced and released by phagocytic cells.
The oxidation of gold(I) thiomalate (AuSTm) to gold(Ill) by myleoperoxidase-generated
hypochlorite ion was briefly described in an abstract by Beverly and Couri [4]. Their reactions were
effected under conditions mimicking the oxidative burst of phagocytic immune cells. Although
further details were reported in a thesis [5], no full report has appeared in the standard literature and
these studies were limited to the single gold complex, AuSTm. The protein chemistry of gold
complexes has been explored in some detail [1] but relatively less is known about its biological
redox chemistry. A number of lines of evidence suggest that gold(Ill) is readily reduced to gold(I)
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under conditions prevailing in vivo [6,7,8] and that bulk gold in tissues is gold(I) even after
administration of gold(Ill) to laboratory animals [8]. Nonetheless, many reviews point out the
feasibility of oxidation [9-13] and possible reactions have been reported [4,14,15]. Thus, the
observation that gold(Ill), but not gold(I), induces secondary immune responses in laboratory
animals [2] and human patients [3] treated with gold(I) drugs suggests that gold(Ill) is indeed
generated in vivo.
Since generation of gold(Ill) by stimulated macrophages or polymorphoneutrophils has the
potential to dramatically alter the metabolism and anti-arthritic activity, as well as the
immunogenicity, of gold drugs, we have investigated the direct reaction of sodium hypochlorite with
gold thiomalate, gold(I)thioglucose, aurocyanide and auranofin. The MPO-mediated oxidation of
these species was also examined. To facilitate the analysis, we developed an Ion Chromotography
Ion-Pairing technique to quantitate the +1 and +111 oxidation states of gold after forming
dicyanogold(I) and tetracyanogold(lll), respectively, in situ.
Conditions underwhich the same enzyme, MPO, can produce cyanide from thiocyanate and
subsequently generate aurocyanide [Au(CN)2-] from AuSTm have also been reported [16].
Therefore, it was also of interest to examine the reaction(s) of aurocyanide with serum albumin, the
principle gold binding protein in blood.
EXPERIMENTAL PROCEDURES
Materials. Gold Thiomalate (H2AuSTm; aurothioapfelsiure, lot #192129) was a kind gift from E.
Tosse GmbH & Co., Hamburg. Sodium hypochlorite (5% solution, Sigma, St. Louis) was diluted
daily to 0.6-5 mM in dd H20 or PBS and quanititated using the taurine/thionitrobenzoate method
[17]. Thio-nitrobenzoate (TNB) solutions (3-4 mM) were prepared by NaBH4 reduction of
5,5’-dithiobis-(2-nitrobenzoic aid) (DT.NB), stored frozen, and quantitated daily by their absorbance
at 412 nm e412 13,600 M- cm- ). KAu(CN)2 was a gift of Dr. Anne Arendt (nee Hormann)
[18]. Reactions were carried out in phosphate buffered saline solution (PBS 50 mM phosphate,
132 mM NaCI, pH 7.4). HCI (1.0 M standardized) was from E. Merck (Darmstadt Germany).
Solutions (10 mM) of KCN (Sigma, Germany were prepared fresh daily.
Chemical Oxidation
Reactions of OCI- with AuSTm, Au(STm)2-, AuSTg, Au(CN)2- or auranofin were carried
out in PBS, pH 7.4 at room temperature. Concentrations were typically 10-80 #M AuSTm and
10-900M OCI-. Gold(Ill) was analyzet as AuCI4- ater acidification of reaction mixtures to pH
1 with 1M HCI (e 1 4860 M- cm- Neither AuSTm nor OCI- absorbs significantly in this 36
wavelength region at acid pH. Gold(I) could be detected qualitatively by conversion to Au(CN)2
in a solution qontaining mM KCN. Intense bands at 204 and 211 nm (on, 12,850 and
10,230 M cm and weaker bands at 230 and 240 nm (2n 3663 and o,n 3441
cm-) provide a distinctive signature. Since the formation constraints for Au(CN) are unusually
large, displacement of simple monodentate ligands is complete [19-21].
Enzyme Mediated Oxidation
Solutions containing typically 10 #g/mL MPO were reacted with gold complexes
([Au(CN)2- ], AuSTm, AuSTg or auranofin; 10-40/M) in PBS, pH 7.4, with H202 (20-100 #M). The
H202 was the last reagent added to initiate the reaction. Temperature was 25C except as noted
otherwise. The reactions were monitored by the absorbance changes at 220 nm. In some cases,
the reaction mixtures were analyzed spectrophotometrically for Au(lll) after addition of HCI, or by
IC after addition of lmM KCN to the reaction mixture. Either reagent at the concentrations used
terminates the enzymatic reaction.
Ion Chromatography
A Dionex20001/SP module equipped with a Chromjet integrator, Ion-Pac Guard Pre-column
(P/N 39567), Ion-Pac MPIC-NS1 column (P/N 35321), Micromembrane Suppressor (P/N 37106),
and Conductivity Cell Detector was employed. The eluant was 50/50 V/V CH3CN/H20 (Grade
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Figure 1. Time Independence of Au(lll) formation from AuSTm (40 #M) and 4 or 8 equivalents of
OCI-. Conditions: [OCI-] 160 or 320 #M; Phosphate buffered saline solution (PBS), pH 7.4, 25C.
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Figure 2. Redox Titration of AuSTm and Au(STm)2- by OCI-. Reaction mixtures were acidfied to
0.10 M HCI one minute after mixing and analyzed spectrophotometrically for Au(lll) by the
absorbance at 316 nm. Conditions: [Au(I)] 80 #M; [OCI-] 80-800 #M; PBS, pH 7.4, 25C.
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deionized) with mM tetrabutylammonium hydroxide, 500 #M Na2CO3. Samples were introduced
via a 50 #L loop and eluted at mL/min. Au(CN)2- and Au(-CN),- standard solutions were
prepared in water and used for elution time and sensitivity calibrations.
RESULTS
Oxidation AuSTm by Hypochlorite
Reactions of OCI- and AuSTm were initially carried out with 40 #M gold and 174 #M OCI-.
Repetitive scans at one minute intervals demonstrated the rapid conversion of AuSTm into a new
species with a more intense absorbance in the 220 nm region followed by a slower change in the
new absorption band. Because the spectrum of gold(Ill) in aqueous solution at neutral pH results
from a mixture of hydroxo and aquo species in a complex equilibrium [21 ], the reaction mixture was
subsequently acidified with HCI to a concentration of 100 mM. The resulting spectrum revealed a
band at 316 nm characteristic of AuCI4- which demonstrates oxidation of the gold(I) to gold(Ill).
The absorbance corresponded to 22.2 #M Au(lll) (40% conversion) in the original solution after 40
min. No gold(Ill) was detected in control solutions containing 160 or 320 #M OCI- but no AuSTm,
or 40 #M AuSTm but no OCI-.
The incomplete reaction observed above could be due to slow kinetics of oxidation, an
equilibrium process, or competing oxidation of the thiomalate ligand. The first possibility was
eliminated by studying extent of reaction between 40/M AuSTm and 160 or 320/M OCI- over 30
minutes. As shown in Figure 1 the extent of reaction is invariant over the time span 1 to 30 minutes,
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240 uH
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Figure 3. Spectrophotometric demonstration of unoxidized gold(I) as Au(CN)2-. Au(STm)2- (20
/M) was treated with 80, 120 or 240 #M OCI- and then adjusted to I mM KCN by adding 0.11 vol
of a 10 mM KCN stock solution. Sharp bands between 204 and 240 nM characteristic of Au(CN)2.- are observed in the solutions with 4 or 6 equivalents of OCI- but not after adding 12 equ=v.
Conditions: PBS, pH 7.4, 25C.
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but dependent on the concentration of OCI-. 320 #M hypochlorite (80CI-/Au(I)) drove the
reaction to completion, but 160 #M OCI- (40CI-/Au(I)) yielded only 55% conversion.
Next a titration was performed measuring the production of Au(lll) as a function of the OCI-
concentration. As shown in Figure 2, the reaction consumes between 2.5 and 3 equivalents of
hypochlorite before the onset of Au oxidation. This corresponds to the oxidation of the thiomalate
to its sulfonic acid form, TmSO3 before the gold can be oxidized:
AuSTm + 3OCI-
AuCI2 + OCI + 3H +
> AuCI2 + TmSO3 + CI
> AuIII + H20 + 3CI-
The ability of the thiomalate to neutralize three equivalents of hypochlorite was confirmed by an
analogous tritration of bis(thiomalato)gold(I), generated in situ from reaction of one equivalent of
thiomalate with AuSTm. In this case extensive formation of gold(Ill) occurred only after five
equivalents of hypochlorite were added, Fig. 2.
The presence of unoxidized gold(I) when fewer than 3 or 6 equivalents of OCI- had been
added to AuSTm or Au(STm)2 respectively, was confirmed by addition of cyanide ion (to mM
final concentration). Au(I) is converted to Au(CN)2 which has four unusually sharp and strong
diagnostic bands in the region 200-240 nm, Fig. 3. The formation constant of Au(CN)2- is
unusually large [23,24]. Facile and complete displacement of thiolates from Au(I) by cyanide has
been previously demonstrated [19-21]. Thus, the presence of Au(I) can be demonstrated
qualitatively in the early but not the later stages of the titration.
Ion Chromatographic Analysis of Au(l) & Au(lll)
To eliminate the ambiguity inherent in UV-visible assessment of the presence of gold(I) and
gold(Ill), a more reliable and quantitative method was developed. Ion chromotography [25] using
an anion column with ion pairing technique was found to be suitable for the detection of gold(I) and
gold(Ill) as their respective cyanide complexes:
AuI(CN)2 and AulII(cN)4
Conductivity measurements provide a sensitive and reproducible method to quantitate the two ions
as they elute from the anion column. Au(CN)2 eluted as a sharp peak at about 3.9 min and
Au(CN)2- as a broader peak at about 6.7 min. The limits of detection were 55 and 110 nM,
respectively; and the linear ranges were found to be 3 to 45 #M and 0.5 to 6 #M. Table gives the
concentrations of gold(I) and gold(Ill) in solutions of AuSTm after reaction with to 3 equivalents
of OCI-. The IC data clearly confirm that the formation of gold(I) commences only after extensive
oxidation of the thiomalate ligand.
Table I. Ion Chromatographic Arysis of AuSTm Oxidation by OCI-
Reactantsa Final Concentrations (#g/mL)b
[AuSTm]/#M [OCI ]/#M OCl-/Au [Au(I)] [Au(lll)]
80 80 0.59 0.00
80 160 2 0.51 0.00
80 240 3 0.42 0.42
aReactions were run in PBS at 25#C. bAnalysis for gold after adding KCN to a final CN-
concentration of 1 mM and further diluting to the linear range of the technique.
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Hypochlorite Oxidation of Other Gold(I) Compounds
AuSTg is also oxidized to Au(lll) by OCI- in a reaction that shares the characteristics of the
AuSTm reaction: preliminary oxidation of the thiolate ligand and then conversion to gold(Ill). The
reaction may be slightly slower as the reaction reaches its endpoint after 2 minutes, not within the
first minute as for AuSTm.
The hypochlorite oxidation of Au(CN)2 was clearly demonstrated by the loss of the
characteristic UV bands at 204, 211,230 and 240 nm [30]. These results indicate that the reactions
of AuSTm and AuSTg are not limited to the gold(I) thiolates but are a characteristic of gold(I)
complexes in general. The presence of Au(lll) was confirmed by the absorbance of AuCI4- and by
IC.
Auranofin (Et3PAuSAtg), which contains a triethylphosphine ligand as well as a thiolate
(2,3,4,6-tetra-O-acetyl-l-thiolato-8-D-glucose) was also examined. The formation of Au(lll)
commenced in this case after four equivalents of hypochlorite were added, which is consistent with
the oxidationo.f the phosphine to Et3PO and thiolate to sulfonate preceeding the oxidation of gold(I)
to gold(Ill). ]P NMR results confirm the formation of Et3PO (A.A. Isab, A. Jagarlamudi, and C.F.
Shaw III, unpublished result).
Myleoperoxidase Mediated Oxidation of ,Gold
Myleoperoxidase is an important enzyme of the oxidative burst. It is present in neutrophils
and to a lesser extent other phagocytic immune cells. During the oxidative burst, it utilizes
hydrogen peroxide to generate hypochlorite from chloride ion:
H202 + CI- > OCI- + H20.
It is likely then that hypochlorite generated by myleoperoxidase can then effect the oxidation of
gold(I) to gold(Ill) under in vivo conditions. To explore this possibility, gold(I) compounds were
exposed to MPO in the presence of its substrates, H202 and chloride ion, to ascertain the feasibility
and the extent of oxidation that would occur. PBS was used as the reaction medium because the
degranulation of neutrophils releases MPO into the extracellular space which has a neutral pH.
The reaction of AuSTm with H20. and CI- in the presence of MPO led to a complex
pattern of changes in the absorbance monitored at 220 nm, Fig. 4. There was an initial decrease
over about 1-2 minutes followed by an increase over the next 2-3 minutes after which the
absorbance leveled off or declined very slowly. The same pattern was observed by Beverly [5].
Control reactions in which CI-, H202, AuSTm or MPO were omitted from the mixture failed to
produce the characteristic decrease and increase in absorbance. Beverly [5] had hypothesized that
the initial decrease is due to the initial oxidation of the thiomalate which disrupts the gold-thiolate
bonds giving rise to broad absorbances in the region 200-240 nm. The inorganic studies above and
IC data below provide strong support for this interpretation. The subsequent increase in absorbance
at 220 nm is due to the formation of Au(lll) as a mixed chloro, aquo, hydroxo complex. Increasing
the AuSTm concentration increased the time required to achieve the minima and maxima in
absorbance, further indicating that both phases involve this complex.
The presence of Au(lll) in the product mixture was confirmed by UV-vis spectroscopy after
conversion to AuCI4 by adding HCI to 0.1 M and by Ion Chromatography after conversion to
Au(CN)4 by adding HCN to mM. Fig. 5 shows ion chromatographs of the same reactant mixture
examined in Fig. 4 before and at 1, 2, 3 and 10 min. following the initiation of reaction. The
decrease in the gold(I) signal (eluting 3.9 min after injection) and the increase in the gold(Ill) signal
(6.7 min after injection) are clearly delineated. The final sample taken 10 minutes after initiating the
reaction shows no detectable gold(I), indicating that complete oxidation was effected.
Oxidation of Au(CN)2- and AuSTg have also been examined in the presence of MPO,
H202 and CI- to generate OCI-. The aurocyanide reaction proceeds with an absorbance increase
at 220 nm after a brief lag phase (ca. 15 sec). The increase is completed within about 2 minutes
and shows a gradual decrease of the next 5-10 minutes. The conversion to Au(lll) was confirmed
by demonstrating the presence AuCI4 after adding HCI to 0.10 M. As the AuSTg reaction
proceeds, the 220 nM absorbance increases and then levels off after about 2-3 min. Thus, it
356G.F. Shaw III, S. Schraa, E. Gleichmann, Y.P. Grover, L. Dunemann and A. Jagarlamudi Metal BasedDrugs
0 30
0
2 MIN
!
I0 MIN
HPO 10 UG/ML
AuSTH 20 uH
HzOz 80 uH
PBS, PH 7.4
25C
0.00
0 2 4 6 8 10
TTME/MIN
Figure 4. Oxidation of AuSTm by OCI- generated by MPO from CI- and H O2. The reaction was 2
conducted at25C in PBS, pH 7.4 and monitored at 220 nm; [MPO] 10 #g]mlL.; [CI-] 132 raM’,
[AuSTIn] 20 #M; [H202] 80/M. Reactions were initiated by addition of H202. In some
reactions, half the mixture was withheld from the spectrometer and sampled before and during (0,
1, 2, 3 & 10 min) the reaction for IC analysis (Fig. 5).
1 MIN MIN 3 MIN 10 HIN
Figure 5. Ion Chromatographic analysis of the changing gold(I) and gold(Ill) content during an
MPO-mediated oxidation of AuSTm (as in Fig 4.). Aliquots removed before and during the reaction
(0, 1, 2, 3, 10 min) were immediately adjusted to mM with KCN to quench the enzymatic reaction
and to convert all Au(I) and Au(lll) species present to Au(CN)2- and Au(CN)4-, respectively. Before
analysis they were diluted to the linear range of the technique.
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resembles the increasing portion of the trace in Fig 4.
spectrophotometrcally.
Au(lll) was again confirmed
Binding of Aurocyanide to Serum Albumin
Au(CN)2.- can be generated in the presence of $CN- under conditions approximating
those found in wvo during chrysotherapy [23] and is found in patients who are non-smokers [24].
These recent reports demonstrate that Au(CN)2- is an important metabolite and that its role in gold
therapy warrants investigation. Many gold complexes react with serum albumin at cys-34 to form
thermodynamically robust complexes which are transported in the blood [1]. Au(CN)-, unlike
AuSTm or AuSTg, accummulates rapidly and extensively in red blood cells, especially =n patients
who smoke [26]. Thus, it is important and necessary to characterize the interaction(s) of
aurocyanide and serum albumin in order to understand the transport and distribution of this
metabolite.
Preliminary studies [Dr. A. A. Isab, 27] with Au(13CN) by.C-13 NMR spectroscopy
suggested extensive association with albumin that was =ndependent of Cys-34, while
chromatographic studies with Au(14CN)2 suggested a very limited extent of reaction via ligand
exchange at Cys-34 to to form AIbSAuCN. To resolve the inherent contradictions additional studies
were undertaken using two additional separation methods. The first is Penefsky chromatography
which rapidly separates free and protein-bound metal ions over a gel-exclusion column using
centrifugal force [28]. The second method is membrane ultrafiltration which preserves the
equilibrium between bound and free metal ion during the separation procedure [29].
Table II. Binding of [Au(CN)2- to Bovine Serum Albumin Determined By3 Independent Separation
Methods.
Au/BSA after separation
Reactant Conventional Penefsky
Au/BSA Gel-Exclusiona Gel-Exclusionb Ultrafiltrationc
1.0 0.05 0.56 0.90
2.5 0.26 2.1
5.0 2.0 3.3
aSephadex G-50 column (1 x 25 cm) eluted by gravity flow with 100 mM NH4HCO3 Buffer, pH 7.9;
,1.1 mM albumin.
Sephadex G-25 column (2 ml syringe) eluted centrifugally with 10 mM phosphate buffer, pH 7.4
+ 100 mM NaCI; 0.4 mM albumin.
CFiltron(R) concentrators (3000 MW cutoff) centrifuged at 5000 x g for 45 min; 10 mM phosphate
buffer, pH 7.4 + 100 mM NaCI; 0.4 mM albumin.
Table II shows the results of the measurements. When one equivalent of Au(CN)2 was
reacted with BSA, the Au/BSA ratio found after separation by conventional chromatography,
Penefsky chromatography and ultrafiltration were 0.05, 0.56 and 0.90, respectively. Clearly the
amount of protein gold binding observed is dependent on the separation technique employed. The
ultrafiltration results confirm the NMR results: extensive association of Au(CN)2 with albumin. The
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NMR experiment is conducted in a single vessel without separation and it, like the ultrafiltration,
maintains the equilibrium between free and bound aurocyanide. The Penefsy columns produce
results that are intermediate between the equilibrium result and the elution over a large column by
gravity flow.
Analysis of the ultrafiltration data establishes that there are two classes of equilibrium
binding sites [29] and provides equilibrium constants for them:
K 5.5x104, n 0.8
Au(CN)2 + Albumin Albumin’(Au(CN)2 )T
Au(CN)2 + Albumin.(Au(CN)2 -)T
K2 5.5x105,n2 3
Albumin.(Au(CN)2 -)T(Au(cN)2 )W
The labile equilibrium binding of aurocyanide to albumin provides a conceptual basis for rationalizing
the disparate results of the three separation methods. At equilibrium, extensive binding is observed
and, as expected for the association constants, the measured Au/BSA ratio is large. The
conventional columns were eluted over a period exceeding an hour. The albumin moves through
the column more rapidly than the trailing low molecular weight species, allowing the Au(CN)2 to
dissociate and be irreversibly lost. The Penefsky columns are rapidly eluted. During the short time
that the albumin is in contact with the resin (< min) there is relatively less opportunity for
dissociation so that an intermediate value is obtained.
DISCUSSION
The oxidation of gold(I) to gold(Ill) was found previously for AuSTm [4,5] and here for AuSTm,
Au(STm)2-, AuSTg, Au(CN)2- and auranofin to be complete with micromolar concentrations of
gold andhypochlorite. The plausibility of these findings can be evaluated using standard reduction
potentials [31,32]:
HOCI + H + + 2e- CI- + H20 Eo, 1/2- +1.49volts
AuCI4 + 2e AuCI2 + 2CI Eo,1/2 +0.93 volts
We use here the potential for gold chlorides which is more meaningful than that for the hypothetical
and non-existent aquo complexes, Au
/ and Au
/ 3. This approach is appropriate since the results
of Fig. 2 require oxidation of the thiolate ligand in AuSTm to proceed gold oxidation and chloride
is likely to ligate gold thereafter. For the net reaction, the potential is
AuCI2 + HOCI + H + + CI AuCI4 + H20 Eo,rxn- +0.56 volts
Using the well known relationship Eo (RT/nF)log K, one can calculate an equilibrium constant
and convert it to an apparent value, Kapp, at physiological conditions (150 mM chloride ion and pH
7.4):
Kapp 1010"73 M-1 [AuCI4-]/[AuCI2-][HOCI
The ratio of Au(lll) to Au(I) can be estimated as K x [HOCI] Assuming a minimum concentration a
of /zM HOCI is maintained during the oxidative PbPurst, the numerical ratio exceeds 105. In other
words, the conversion of gold(I) to gold(Ill) should be complete under conditions of the oxidative
burst. (This result is independent of the selection of the acid or basic solution Eo value for
HOCl/OCl-).
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Graham etaL [23] have demonstrated that myleoperoxidase-generated hypochlorite can convert
physiological concentrations of SCN- to CN- which in the presence of AuSTm reacts further to
form Au(CN)2-. It has been shown here that Au(CN)2- can be oxidized to Au(lll). If an excess
of cyanide is present, Au(CN)4- will form due to the thermodynamically favorable and kinetically
facile ligand exchange reactions that favor cyanide over chloride, thiocyanate or water ligands.
Thus, the gold(Ill) species formed in viva may be Au(CN)4- as shown in the flow diagram of Fig
6. The UV spectrum of Au(CN)4 is featureless in the region 200-500 cm and the complex would
not be detected by UV-vis spectroscopy. Further studies of this interesting possibility, using other
detection methods, are planned.
AuSTIn
SCN
MPO, OCI
(Graham et al )
CN
(Graham et al )
Au(CN), --
MPO, OCI
(Shaw, Gleichmann et al )
Au(CN)2CI
SCN
MPO, OCI
(Graham et al )
Figure 6. Is Au(CN)4 a metabolite of gold(I) drugs? The scheme show a plausible route based
on the work here and previous results of Rudkowski et al. [23] by which it may form during the
oxidative burst.
The favorable thermodynamics and the rapidity of the oxidation of gold(I) by thiomalate suggest
that a gold(I)-gold(lll) redox cycle can be established in viva:
OCI- (MPO generated)
thiols, thioethers, disulfides
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Our studies of the reduction of AuCI4- and Au(CN)4 by serum albumin and various thiols and
thioethers (Isab, Jagaralmudi, Schraa and Shaw, unpublished) suggest that the reduction is
somewhat slower than hypochlorite oxidation of gold(I). When the forward reaction occurs as
rapidly as hypochlorite is generated, as found here, and the reverse reaction over a few minutes,
kinetic considerations imply that a significant fraction of the gold present at the site of the oxidative
burst can accumulate in the form of gold(Ill). This powerful oxidant can then diffuse away from the
site and react with protein reductants that are encountered.
This, in turn, can have immunological consequences associated with both the clinical benefits
and the side effects of chrysotherapy. Oxidation of proteins can convert self-proteins into "non-self
proteins" causing peptides presented by HLA molecules of antigen-presenting cells to elicit immune
responses as found in several side effects to gold therapy. Alternatively, this oxidation could alter
the structure of proteins that are already being detected as non-self in the pathogenesis of
rheumatoid arthritis. This could, in turn, inhibit their binding to HLA molecules, and, therefore,
minimize or inhibit their subsequent recognition by T-cells leading to an observable clinical
improvement in the disease state.
Further research on the details of gold(Ill) formation and its re-reduction by model proteins and
the consequences of such reactions for the generation of cryptic peptides during antigen processing
are crucial to a more detailed understanding of the mechanism of action of gold-based anti-arthritic
agents.
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